Effects of Azathioprine and Mycophenolate Mofetil-Immunosuppressive Regimens on the Erythropoietic System of Renal Transplant Recipients

Transplantation Proceedings

Volumn 38, Issue 7, 2006, Pages 2077-2079

  Khosroshahi, H T ^a   Asghari, A ^a   Estakhr, R ^a   Baiaz, B ^a   Ardalan, M R ^a   Shoja, M M ^a  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; ERYTHROPOIETIN; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ANEMIA; ARTICLE; BLOOD LEVEL; BONE MARROW SUPPRESSION; DIARRHEA; ERYTHROCYTE COUNT; ERYTHROPOIESIS; FEMALE; HEMATOCRIT; HEMOGLOBIN DETERMINATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECIPIENT; THROMBOCYTOPENIA;

AZATHIOPRINE; DRUG THERAPY, COMBINATION; ERYTHROCYTE COUNT; ERYTHROPOIESIS; ERYTHROPOIETIN; FOLLOW-UP STUDIES; HEMATOCRIT; HEMOGLOBINS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MYCOPHENOLIC ACID; PREDNISOLONE; TRANSPLANTATION, HOMOLOGOUS;

EID: 33846098257     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.06.043     Document Type: Article

References (9)

1. Krensky A.M., Strom T.B., and Bluestone J.A. Immunomodulators. In: Hardman J.G., and Limbird L.E. (Eds). Goodman and Gilman's-The Pharmacological Basis of Therapeutics. 10th ed. (2001), McGraw-Hill, New York 1463
2. Chandraker A., Perkins D.L., Carpenter C.B., et al. Transplantation Immunobiology, Brenner & Rector's-The Kidney. 7th ed. vol 3 (2004), Saunders, Philadelphia
3. Meier-Kriesche H.U., Morris J.A., Chu A.H., et al. Mycophenolate mofetil vs azathioprine in a large population of elderly renal transplant patients. Nephrol Dial Transplant 19 (2004) 2864
4. Mathew T.H., and Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. A blinded, long-term, randomized multicenter study of mycophenolate mofetil in cadaveric renal transplantation: results at three years. Transplantation 65 (1998) 1450
5. Sollinger H.W., and U.S. Renal Transplant Mycophenolate Mofetil Study Group. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. Transplantation 60 (1995) 225
6. Gema F.F., Carlos R.J., and Emilio R. Prevalence of anemia in renal transplant recipients: result from MOST, an observational trial. (Abstract). Nephrol Dial Transplant 20 suppl 5 (2005) 270
7. Shah N., Haydar A.A., Al Khoury S., et al. Prevalence and determinants of post renal transplantation anemia-a two center study of 1122 patients. (Abstract). Nephrol Dial Transplant 20 suppl 5 (2005) 271
8. Knoll G.A., MacDonald I., Khan A., et al. Mycophenolate mofetil dose reduction and the risk of acute rejection after renal transplantation. J Am Soc Nephrol 14 (2003) 2381
9. Roth D., Colona J., Burke G.W., et al. Primary immunosuppression with tacrolimus and mycophenolate mofetil for renal allograft recipients. Transplantation 65 (1998) 248